Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105766643 | 10576664 | 3 | F | 20131115 | 20160719 | 20141111 | 20160726 | EXP | CH-BRISTOL-MYERS SQUIBB COMPANY-21581913 | BRISTOL MYERS SQUIBB | 28.00 | YR | F | Y | 0.00000 | 20160726 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105766643 | 10576664 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | U | 21436 | 10 | MG | TABLET | QD | |||||
| 105766643 | 10576664 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | U | 21436 | TABLET | ||||||||||
| 105766643 | 10576664 | 3 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | U | 0 | 40 | MG | QD | ||||||
| 105766643 | 10576664 | 4 | SS | LATUDA | LURASIDONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 105766643 | 10576664 | 5 | SS | CIPRALEX | ESCITALOPRAM OXALATE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 105766643 | 10576664 | 6 | SS | CIPRALEX | ESCITALOPRAM OXALATE | 1 | U | 0 | |||||||||||
| 105766643 | 10576664 | 7 | SS | SEROPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 105766643 | 10576664 | 8 | SS | SEROPRAM | CITALOPRAM HYDROBROMIDE | 1 | U | 0 | |||||||||||
| 105766643 | 10576664 | 9 | SS | EDRONAX | REBOXETINE MESYLATE | 1 | Oral | 4 MG, QD | U | 0 | 4 | MG | QD | ||||||
| 105766643 | 10576664 | 10 | SS | EDRONAX | REBOXETINE MESYLATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105766643 | 10576664 | 1 | Panic attack |
| 105766643 | 10576664 | 2 | Depression |
| 105766643 | 10576664 | 3 | Panic attack |
| 105766643 | 10576664 | 4 | Depression |
| 105766643 | 10576664 | 5 | Panic attack |
| 105766643 | 10576664 | 6 | Depression |
| 105766643 | 10576664 | 7 | Panic attack |
| 105766643 | 10576664 | 8 | Depression |
| 105766643 | 10576664 | 9 | Panic attack |
| 105766643 | 10576664 | 10 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105766643 | 10576664 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105766643 | 10576664 | Caesarean section | |
| 105766643 | 10576664 | Maternal exposure during pregnancy | |
| 105766643 | 10576664 | Metrorrhagia | |
| 105766643 | 10576664 | Off label use | |
| 105766643 | 10576664 | Premature delivery | |
| 105766643 | 10576664 | Premature rupture of membranes |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |